chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional dose omission
Clinical narrative: first Moderna COVID-19 dose on 23Apr2021, and hasn't received the second dose yet as she is afraid of needles; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first Moderna COVID-19 dose on 23Apr2021, and hasn't received the second dose yet.) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first Moderna COVID-19 dose on 23Apr2021, and hasn't received the second dose yet.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first Moderna COVID-19 dose on 23Apr2021, and hasn't received the second dose yet.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment was reported. No concomitant medication was reported. Patient is afraid of needles which is why she hasn't gotten the second dose.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Nasopharyngitis
Clinical narrative: COLD; SWEATING; HEADACHE; This spontaneous case was reported by a patient and describes the occurrence of NASOPHARYNGITIS (COLD), HYPERHIDROSIS (SWEATING) and HEADACHE (HEADACHE) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21A and 033C21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included OLANZAPINE HYDROCHLORIDE for an unknown indication.   On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jun-2021, the patient experienced NASOPHARYNGITIS (COLD) and HEADACHE (HEADACHE). 22-Jun-2021, the patient experienced HYPERHIDROSIS (SWEATING). At the time of the report, NASOPHARYNGITIS (COLD), HYPERHIDROSIS (SWEATING) and HEADACHE (HEADACHE) outcome was unknown.            No treatment drug details was reported.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Throat irritation
Clinical narrative: Scratchy throat; Swelling of lymph nodes (collar bone, jaw, ribs); Soreness; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Scratchy throat), LYMPHADENOPATHY (Swelling of lymph nodes (collar bone, jaw, ribs)) and MYALGIA (Soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C27A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROAT IRRITATION (Scratchy throat), LYMPHADENOPATHY (Swelling of lymph nodes (collar bone, jaw, ribs)) and MYALGIA (Soreness). At the time of the report, THROAT IRRITATION (Scratchy throat), LYMPHADENOPATHY (Swelling of lymph nodes (collar bone, jaw, ribs)) and MYALGIA (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Vaccination site induration, Vaccination site pain, Vaccination site swelling
Clinical narrative: Shortness of breath; Chest pain; Huge baseball size lump at the injection site was very hard; After second vaccine appeared a huge baseball sized lump at injection site; Huge baseball size lump at the injection site was very sore; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), CHEST PAIN (Chest pain), VACCINATION SITE INDURATION (Huge baseball size lump at the injection site was very hard), VACCINATION SITE SWELLING (After second vaccine appeared a huge baseball sized lump at injection site) and VACCINATION SITE PAIN (Huge baseball size lump at the injection site was very sore) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. o14cz1A and o4ob218) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced DYSPNOEA (Shortness of breath), CHEST PAIN (Chest pain), VACCINATION SITE INDURATION (Huge baseball size lump at the injection site was very hard), VACCINATION SITE SWELLING (After second vaccine appeared a huge baseball sized lump at injection site) and VACCINATION SITE PAIN (Huge baseball size lump at the injection site was very sore). On 25-May-2021, DYSPNOEA (Shortness of breath) and CHEST PAIN (Chest pain) had resolved. At the time of the report, VACCINATION SITE INDURATION (Huge baseball size lump at the injection site was very hard), VACCINATION SITE SWELLING (After second vaccine appeared a huge baseball sized lump at injection site) and VACCINATION SITE PAIN (Huge baseball size lump at the injection site was very sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter.  No treatment medication was provided.  Action take with mRNA-1273 in response to the events were not applicable.  On the night of vaccination day she went to the Amita Community Hospital ER, located in Munster, Indiana, with chest pain and shortness of breath, and they took tests. She had a really hard time breathing, and these side effects were resolved, after her release the same day.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Started getting rash on top of both hands that lasted for months; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Started getting rash on top of both hands that lasted for months) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 040A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced RASH (Started getting rash on top of both hands that lasted for months). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at a dose of 1 UNK. At the time of the report, RASH (Started getting rash on top of both hands that lasted for months) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication include Steroid cream.     This case was linked to MOD-2021-235140 (Patient Link).
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were provided   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up information received on 07-jul-2021 contains non significant information as another reporter added.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: pregnant after receiving 1st dose of Moderna COVID-19 vaccine; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant after receiving 1st dose of Moderna COVID-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (pregnant after receiving 1st dose of Moderna COVID-19 vaccine). At the time of the report, EXPOSURE DURING PREGNANCY (pregnant after receiving 1st dose of Moderna COVID-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported.  No treatment medication details was reported.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Cardiac stress test, Computerised tomogram, Dyspnoea
Clinical narrative: Shortness of breath / while going for a walk it was hard to catch her breath; no energy like energy is fully drained; blood pressure is off the wall; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath / while going for a walk it was hard to catch her breath), ASTHENIA (no energy like energy is fully drained) and HYPERTENSION (blood pressure is off the wall) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 004H20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), CALCIUM MEFOLINATE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B12 NOS (METANX) and ATORVASTATIN for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath / while going for a walk it was hard to catch her breath), ASTHENIA (no energy like energy is fully drained) and HYPERTENSION (blood pressure is off the wall). The patient was treated with AMLODIPINE at a dose of 5 mg. At the time of the report, DYSPNOEA (Shortness of breath / while going for a walk it was hard to catch her breath), ASTHENIA (no energy like energy is fully drained) and HYPERTENSION (blood pressure is off the wall) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: (Inconclusive) Normal. On an unknown date, Cardiac stress test: (normal) Normal. On an unknown date, Computerised tomogram: (normal) Clear. On an unknown date, Echocardiogram: (normal) Clear. On an unknown date, Pulmonary function test normal: (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Bunch of vitamins includes in the concomitant medication.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram, Hypertension, Pulmonary function test normal
Clinical narrative: Shortness of breath / while going for a walk it was hard to catch her breath; no energy like energy is fully drained; blood pressure is off the wall; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath / while going for a walk it was hard to catch her breath), ASTHENIA (no energy like energy is fully drained) and HYPERTENSION (blood pressure is off the wall) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 004H20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), CALCIUM MEFOLINATE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B12 NOS (METANX) and ATORVASTATIN for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath / while going for a walk it was hard to catch her breath), ASTHENIA (no energy like energy is fully drained) and HYPERTENSION (blood pressure is off the wall). The patient was treated with AMLODIPINE at a dose of 5 mg. At the time of the report, DYSPNOEA (Shortness of breath / while going for a walk it was hard to catch her breath), ASTHENIA (no energy like energy is fully drained) and HYPERTENSION (blood pressure is off the wall) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: (Inconclusive) Normal. On an unknown date, Cardiac stress test: (normal) Normal. On an unknown date, Computerised tomogram: (normal) Clear. On an unknown date, Echocardiogram: (normal) Clear. On an unknown date, Pulmonary function test normal: (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Bunch of vitamins includes in the concomitant medication.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Soreness in the arm on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness in the arm on the injection site) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (Soreness in the arm on the injection site). At the time of the report, INJECTION SITE PAIN (Soreness in the arm on the injection site) outcome was unknown.            Concomitant product information was not provided. Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow-up received and contains non significant information
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.). At the time of the report, PRODUCT STORAGE ERROR (pre-drawn syringes that were withdrawn and left out at room temperature for over 12 hours. At least one to three of the doses were administered to patients.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No Treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Non Significant Follow-up information was added; Reporter address was added.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Should get her second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Should get her second dose   ) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Should get her second dose   ). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Should get her second dose   ) had resolved.            No concomitant medications were reported.  No treatment information was provided.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Myalgia, Pyrexia, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: fever; aches; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), MYALGIA (aches) and VACCINATION SITE PAIN (Vaccination site pain) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included COVID-19 on 04-May-2021. Concomitant products included METFORMIN for an unknown indication.    On 23-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On an unknown date, the patient experienced PYREXIA (fever) and MYALGIA (aches). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 25-May-2021, PYREXIA (fever), MYALGIA (aches) and VACCINATION SITE PAIN (Vaccination site pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-May-2021, SARS-CoV-2 test: positive (Positive) positive. On an unknown date, Heart rate: 122 (High) 122 beats per minute.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Muscular weakness, Weight decreased
Clinical narrative: not eating well for a couple of days; loss of weight,; muscular weakness; felt tired; headache; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (not eating well for a couple of days), WEIGHT DECREASED (loss of weight,), MUSCULAR WEAKNESS (muscular weakness), FATIGUE (felt tired) and HEADACHE (headache) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, the patient experienced DECREASED APPETITE (not eating well for a couple of days), WEIGHT DECREASED (loss of weight,), MUSCULAR WEAKNESS (muscular weakness), FATIGUE (felt tired) and HEADACHE (headache). At the time of the report, DECREASED APPETITE (not eating well for a couple of days), WEIGHT DECREASED (loss of weight,), MUSCULAR WEAKNESS (muscular weakness), FATIGUE (felt tired) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment included plus protein.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Dizziness, Dyspnoea, Wheezing
Clinical narrative: Wheezing; Shortness of breath,She cannot walk much without getting shortness of breath; Dizziness; Asthma got worse; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (Wheezing), DYSPNOEA (Shortness of breath,She cannot walk much without getting shortness of breath), DIZZINESS (Dizziness) and ASTHMA (Asthma got worse) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included ALBUTEROL [SALBUTAMOL] for an unknown indication.   On 09-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WHEEZING (Wheezing), DYSPNOEA (Shortness of breath,She cannot walk much without getting shortness of breath), DIZZINESS (Dizziness) and ASTHMA (Asthma got worse). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency and NAPROXEN at an unspecified dose and frequency. At the time of the report, WHEEZING (Wheezing), DYSPNOEA (Shortness of breath,She cannot walk much without getting shortness of breath), DIZZINESS (Dizziness) and ASTHMA (Asthma got worse) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 16-Aug-2021: Follow up document received and patient email details had been updated. Nonsignificant information
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Markedly blurred vision on both eyes; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Markedly blurred vision on both eyes) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and #040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VISION BLURRED (Markedly blurred vision on both eyes). At the time of the report, VISION BLURRED (Markedly blurred vision on both eyes) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Doses administered in pre-drawn syringes left out for over 12 hours at room temperature; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered in pre-drawn syringes left out for over 12 hours at room temperature) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered in pre-drawn syringes left out for over 12 hours at room temperature). On 24-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered in pre-drawn syringes left out for over 12 hours at room temperature) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Joint swelling, Myalgia
Clinical narrative: For the last 3 weeks her hip has been hurting bad; pain at the injection site; the same night of the vaccine she had body soreness; Headache; tired; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (pain at the injection site), MYALGIA (the same night of the vaccine she had body soreness), HEADACHE (Headache), FATIGUE (tired) and JOINT SWELLING (For the last 3 weeks her hip has been hurting bad) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced INJECTION SITE PAIN (pain at the injection site), MYALGIA (the same night of the vaccine she had body soreness), HEADACHE (Headache) and FATIGUE (tired). On an unknown date, the patient experienced JOINT SWELLING (For the last 3 weeks her hip has been hurting bad). At the time of the report, INJECTION SITE PAIN (pain at the injection site), MYALGIA (the same night of the vaccine she had body soreness), HEADACHE (Headache), FATIGUE (tired) and JOINT SWELLING (For the last 3 weeks her hip has been hurting bad) outcome was unknown.            Concomitant product included insulin pump. Treatment medications information was not provided.   This case was linked to MOD-2021-235348 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Eye pruritus
Clinical narrative: Itchy eyes; This spontaneous case was reported by a consumer and describes the occurrence of EYE PRURITUS (Itchy eyes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, the patient experienced EYE PRURITUS (Itchy eyes). At the time of the report, EYE PRURITUS (Itchy eyes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arm; a little tired / took the day off from work; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (a little tired / took the day off from work) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (a little tired / took the day off from work). At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (a little tired / took the day off from work) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided by the reporter.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Vaccination site pain
Clinical narrative: For the last 3 weeks her hip has been hurting bad; pain at the injection site; the same night of the vaccine she had body soreness; headache; tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site), MYALGIA (the same night of the vaccine she had body soreness), HEADACHE (headache), FATIGUE (tired) and ARTHRALGIA (For the last 3 weeks her hip has been hurting bad) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic. Concomitant products included INSULIN for an unknown indication.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site), MYALGIA (the same night of the vaccine she had body soreness), HEADACHE (headache) and FATIGUE (tired). On an unknown date, the patient experienced ARTHRALGIA (For the last 3 weeks her hip has been hurting bad). At the time of the report, VACCINATION SITE PAIN (pain at the injection site), MYALGIA (the same night of the vaccine she had body soreness), HEADACHE (headache), FATIGUE (tired) and ARTHRALGIA (For the last 3 weeks her hip has been hurting bad) outcome was unknown.            No treatment details were reported.   This case was linked to MOD-2021-235316 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products and treatment medication were reported.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     The patient's past medical history included Broken wrist and Lung lobectomy (Upper left lung lobe removed). Concurrent medical conditions included Trigeminal neuralgia, Sciatica, Chronic back pain and Lung cancer. Concomitant products included METHADONE, HYDROMORPHONE, ALPRAZOLAM, DULOXETINE HYDROCHLORIDE (CYMBALTA) and TRAZODONE for an unknown indication.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 12-May-2021, VACCINATION SITE PAIN (Soreness at the injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information was not reported.   This case was linked to MOD-2021-235431 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: No new information received.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Vertigo
Clinical narrative: event happned 9 days post vaccination/severe episode of vertigo; event happned 9 days post vaccination/sever episode of vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (event happned 9 days post vaccination/severe episode of vertigo) and CONDITION AGGRAVATED (event happned 9 days post vaccination/sever episode of vertigo) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy. Concomitant products included LOSARTAN POTASSIUM (LOSARTIN) for Blood pressure high.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced VERTIGO (event happned 9 days post vaccination/severe episode of vertigo) and CONDITION AGGRAVATED (event happned 9 days post vaccination/sever episode of vertigo). At the time of the report, VERTIGO (event happned 9 days post vaccination/severe episode of vertigo) and CONDITION AGGRAVATED (event happned 9 days post vaccination/sever episode of vertigo) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Allergic to medications and other products No treatment drugs were provided   This case was linked to MOD-2021-057718 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (body aches). At the time of the report, MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Influenza like illness, Limb discomfort, Nasopharyngitis
Clinical narrative: mild biting in my arm the day of then a week later; Then a week later I feel like I have the flu; I have a bad cold; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (mild biting in my arm the day of then a week later), INFLUENZA LIKE ILLNESS (Then a week later I feel like I have the flu) and NASOPHARYNGITIS (I have a bad cold) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (mild biting in my arm the day of then a week later), INFLUENZA LIKE ILLNESS (Then a week later I feel like I have the flu) and NASOPHARYNGITIS (I have a bad cold). At the time of the report, LIMB DISCOMFORT (mild biting in my arm the day of then a week later), INFLUENZA LIKE ILLNESS (Then a week later I feel like I have the flu) and NASOPHARYNGITIS (I have a bad cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood pressure measurement, Body temperature, Chills, Confusional state
Clinical narrative: freezing; couldn't walk; couldn't think; had anxiety; rapid heart rate; in bed; existing pain was exacerbated/achy from head to toe; sinus infection; typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe); This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe)), SINUSITIS (sinus infection), GAIT DISTURBANCE (couldn't walk), CONFUSIONAL STATE (couldn't think) and ANXIETY (had anxiety) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A and 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METHADONE, HYDROMORPHONE, ALPRAZOLAM, DULOXETINE HYDROCHLORIDE (CYMBALTA) and TRAZODONE for an unknown indication.   On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jun-2021, the patient experienced INFLUENZA (typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe)). On 10-Jun-2021, the patient experienced SINUSITIS (sinus infection). On 11-Jun-2021, the patient experienced GAIT DISTURBANCE (couldn't walk), CONFUSIONAL STATE (couldn't think), ANXIETY (had anxiety), TACHYCARDIA (rapid heart rate), ILLNESS (in bed) and MYALGIA (existing pain was exacerbated/achy from head to toe). On an unknown date, the patient experienced CHILLS (freezing). The patient was treated with IBUPROFEN for Pain, at a dose of 1 dosage form; PARACETAMOL (TYLENOL) from 07-Jun-2021 to 09-Jun-2021 for Fever, at a dose of 1 dosage form and DOXYCYCLINE from 10-Jun-2021 to 14-Jun-2021 for Sinus infection, at a dose of 100 milligram twice a day. On 09-Jun-2021, INFLUENZA (typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe)) outcome was unknown. On 13-Jun-2021, TACHYCARDIA (rapid heart rate) outcome was unknown. On 15-Jun-2021, SINUSITIS (sinus infection), GAIT DISTURBANCE (couldn't walk), CONFUSIONAL STATE (couldn't think), ANXIETY (had anxiety), ILLNESS (in bed) and MYALGIA (existing pain was exacerbated/achy from head to toe) outcome was unknown. At the time of the report, CHILLS (freezing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jun-2021, Body temperature: 104.2 (High) 104.2. On 11-Jun-2021, Blood pressure measurement: 153/101 mmHg (High) 153/101. On 12-Jun-2021, Blood pressure measurement: 150/91-92 mmHg (High) 150/91-92.         This case was linked to MOD-2021-235394 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow up received contains no new information.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Illness, Influenza, Myalgia, Sinusitis
Clinical narrative: freezing; couldn't walk; couldn't think; had anxiety; rapid heart rate; in bed; existing pain was exacerbated/achy from head to toe; sinus infection; typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe); This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe)), SINUSITIS (sinus infection), GAIT DISTURBANCE (couldn't walk), CONFUSIONAL STATE (couldn't think) and ANXIETY (had anxiety) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A and 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METHADONE, HYDROMORPHONE, ALPRAZOLAM, DULOXETINE HYDROCHLORIDE (CYMBALTA) and TRAZODONE for an unknown indication.   On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jun-2021, the patient experienced INFLUENZA (typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe)). On 10-Jun-2021, the patient experienced SINUSITIS (sinus infection). On 11-Jun-2021, the patient experienced GAIT DISTURBANCE (couldn't walk), CONFUSIONAL STATE (couldn't think), ANXIETY (had anxiety), TACHYCARDIA (rapid heart rate), ILLNESS (in bed) and MYALGIA (existing pain was exacerbated/achy from head to toe). On an unknown date, the patient experienced CHILLS (freezing). The patient was treated with IBUPROFEN for Pain, at a dose of 1 dosage form; PARACETAMOL (TYLENOL) from 07-Jun-2021 to 09-Jun-2021 for Fever, at a dose of 1 dosage form and DOXYCYCLINE from 10-Jun-2021 to 14-Jun-2021 for Sinus infection, at a dose of 100 milligram twice a day. On 09-Jun-2021, INFLUENZA (typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe)) outcome was unknown. On 13-Jun-2021, TACHYCARDIA (rapid heart rate) outcome was unknown. On 15-Jun-2021, SINUSITIS (sinus infection), GAIT DISTURBANCE (couldn't walk), CONFUSIONAL STATE (couldn't think), ANXIETY (had anxiety), ILLNESS (in bed) and MYALGIA (existing pain was exacerbated/achy from head to toe) outcome was unknown. At the time of the report, CHILLS (freezing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jun-2021, Body temperature: 104.2 (High) 104.2. On 11-Jun-2021, Blood pressure measurement: 153/101 mmHg (High) 153/101. On 12-Jun-2021, Blood pressure measurement: 150/91-92 mmHg (High) 150/91-92.         This case was linked to MOD-2021-235394 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow up received contains no new information.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: freezing; couldn't walk; couldn't think; had anxiety; rapid heart rate; in bed; existing pain was exacerbated/achy from head to toe; sinus infection; typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe); This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe)), SINUSITIS (sinus infection), GAIT DISTURBANCE (couldn't walk), CONFUSIONAL STATE (couldn't think) and ANXIETY (had anxiety) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A and 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METHADONE, HYDROMORPHONE, ALPRAZOLAM, DULOXETINE HYDROCHLORIDE (CYMBALTA) and TRAZODONE for an unknown indication.   On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jun-2021, the patient experienced INFLUENZA (typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe)). On 10-Jun-2021, the patient experienced SINUSITIS (sinus infection). On 11-Jun-2021, the patient experienced GAIT DISTURBANCE (couldn't walk), CONFUSIONAL STATE (couldn't think), ANXIETY (had anxiety), TACHYCARDIA (rapid heart rate), ILLNESS (in bed) and MYALGIA (existing pain was exacerbated/achy from head to toe). On an unknown date, the patient experienced CHILLS (freezing). The patient was treated with IBUPROFEN for Pain, at a dose of 1 dosage form; PARACETAMOL (TYLENOL) from 07-Jun-2021 to 09-Jun-2021 for Fever, at a dose of 1 dosage form and DOXYCYCLINE from 10-Jun-2021 to 14-Jun-2021 for Sinus infection, at a dose of 100 milligram twice a day. On 09-Jun-2021, INFLUENZA (typical flu stuff (freezing, normal body temperature is 97.5 F but it was 102.4 F, achy from head to toe)) outcome was unknown. On 13-Jun-2021, TACHYCARDIA (rapid heart rate) outcome was unknown. On 15-Jun-2021, SINUSITIS (sinus infection), GAIT DISTURBANCE (couldn't walk), CONFUSIONAL STATE (couldn't think), ANXIETY (had anxiety), ILLNESS (in bed) and MYALGIA (existing pain was exacerbated/achy from head to toe) outcome was unknown. At the time of the report, CHILLS (freezing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jun-2021, Body temperature: 104.2 (High) 104.2. On 11-Jun-2021, Blood pressure measurement: 153/101 mmHg (High) 153/101. On 12-Jun-2021, Blood pressure measurement: 150/91-92 mmHg (High) 150/91-92.         This case was linked to MOD-2021-235394 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow up received contains no new information.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: I believe there were doses given after being in the refrigerator for the 30 days; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (I believe there were doses given after being in the refrigerator for the 30 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (I believe there were doses given after being in the refrigerator for the 30 days). On 24-Jun-2021, EXPIRED PRODUCT ADMINISTERED (I believe there were doses given after being in the refrigerator for the 30 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.